How to judge a supplement
What a supplement label can and cannot tell you, how safe amounts are set, what quality marks verify, and which claims are warning signs. Each statement is tied to the regulation, FDA or NIH page it comes from.
21 CFR 190.6(a); 21 CFR 101.93(a)(1); Tucker et al., JAMA Netw Open 2018; eCFR full-text search, October 28, 2026.
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Ask a doctor or pharmacist before starting a supplement, particularly with medicines, in pregnancy or for a child.
Related: Supplements A–Z · Documented interactions · Why supplements cannot claim to treat disease
The checks in brief
Ten checks cover most of what a buyer can verify without a laboratory. The sections below give the rule or source behind each one.
What FDA does and does not do
A supplement reaches the shelf without FDA review of whether it works or is safe. The company is responsible for both, and FDA acts mainly after sale. Two notices go to FDA before or soon after sale: one for a new dietary ingredient, one for a structure/function statement. Neither is an approval.
| Step | Rule or FDA statement | Detail | Source |
|---|---|---|---|
| Approve a supplement for safety and effectiveness before sale | No. FDA “does NOT have the authority to approve dietary supplements for safety and effectiveness” before they reach the public. | The company is responsible for meeting the safety standards of the law. | FDA 101 |
| New dietary ingredient | The company notifies FDA at least 75 days before introducing a supplement with the ingredient into interstate commerce. | FDA replies with a letter of acknowledgment without objection, an objection letter, or a letter listing deficiencies. An acknowledgment “does not constitute an independent finding by FDA” that the ingredient and supplement are safe; silence is not a finding either. | 21 CFR 190.6 FDA NDIN guidance 2024 |
| Structure/function statement on the label | The company notifies FDA no later than 30 days after first marketing. | The label carries: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” | 21 CFR 101.93 |
| Manufacturing | Current good manufacturing practice, 21 CFR Part 111 (subparts A–P). | At least one appropriate test or examination to verify the identity of each dietary ingredient; specifications for identity, purity, strength and composition of each finished batch. | 21 CFR Part 111 |
| After the product is on sale | FDA's role “primarily begins after the product enters the marketplace.” | FDA inspects facilities, reviews labels and websites, and monitors adverse event reports. | FDA 101 |
| Serious adverse events | The company named on the label reports each serious adverse event report it receives within 15 business days. | Records are kept for 6 years. Consumers can report through FDA's Safety Reporting Portal. | 21 U.S.C. 379aa-1 FDA reporting page |
Reading the Supplement Facts panel
The panel's content is set by 21 CFR 101.36. %DV compares the amount per serving with the Reference Daily Intake in 21 CFR 101.9; ingredients without one carry an asterisk instead. A botanical must name the plant part, and its Latin name unless the common name is standardized in Herbs of Commerce.
| Element | Requirement | Rule | Source |
|---|---|---|---|
| Title | “Supplement Facts,” in a type size larger than all other print in the nutrition label | § 101.36(e)(1) | 21 CFR 101.36 |
| Serving size | Expressed in a term appropriate to the form (for example, capsule, tablet, scoop) | § 101.36(b)(1)(i) | 21 CFR 101.36 |
| % Daily Value | For nutrients with a Reference Daily Intake: amount per serving ÷ RDI. Vitamin D: 25 mcg ÷ 20 mcg = 125%. Zinc: 11 mg ÷ 11 mg = 100% | § 101.36(b)(2); RDIs in § 101.9(c)(8)(iv) | 21 CFR 101.36 21 CFR 101.9(c)(8)(iv) |
| No Daily Value | A symbol such as an asterisk in the %DV column, with the footnote “Daily Value not established” | § 101.36(b) | 21 CFR 101.36 |
| Other dietary ingredients | Listed by common or usual name with the quantity by weight per serving | § 101.36(b)(3) | 21 CFR 101.36 |
| Source ingredient | May be named in parentheses, for example “Zinc (as zinc gluconate)” | § 101.36(d) | 21 CFR 101.36 |
| Botanicals | The part of the plant (root, leaves) must be stated; the Latin binomial is added in parentheses unless the common name is listed in Herbs of Commerce (1992) | § 101.36(d)(1); § 101.4(h)(1)–(2) | 21 CFR 101.36 21 CFR 101.4(h) |
| Proprietary blend | Identified as “Proprietary Blend” or another descriptive or fanciful name, with the total weight of the blend and its components in descending order of predominance by weight | § 101.36(c) | 21 CFR 101.36 |
Show data: Reference Daily Intakes used for %DV (adults and children 4 years and older)
| Nutrient | RDI |
|---|---|
| Vitamin C | 90 mg |
| Vitamin D | 20 mcg |
| Calcium | 1,300 mg |
| Iron | 18 mg |
| Magnesium | 420 mg |
| Zinc | 11 mg |
| Vitamin B12 | 2.4 mcg |
21 CFR 101.9(c)(8)(iv), eCFR, retrieved October 28, 2026.
Proprietary blends
A proprietary blend must show its total weight and list its components in descending order of predominance by weight (21 CFR 101.36(c)). The amount of each component is not required, so the label cannot show whether any one of them is present at an amount used in a study.
| From the label you can learn | From the label you cannot learn |
|---|---|
| The blend's name and total weight per serving | The weight of each component |
| Which components are in it, heaviest first | Whether a component matches an amount studied in people |
| For botanicals, the plant part (and Latin name where required) | Whether a component is standardized, and to what |
21 CFR 101.36(c) and (d)(1); 21 CFR 101.4(h). The right-hand column follows from what the rule does not require.
How a safe amount is set
For vitamins and minerals, the National Academies set an RDA for adequacy and a Tolerable Upper Intake Level (UL) for safety. A UL starts from the highest intake with no observed adverse effect (NOAEL), or the lowest with one (LOAEL), divided by an uncertainty factor. Check what each UL covers: some count food and supplements together (vitamin B6), others only supplemental or synthetic forms (vitamin E, folate). The method in more depth: risk assessment.
| Value | Definition | Source |
|---|---|---|
| RDA (Recommended Dietary Allowance) | Average daily intake sufficient to meet the requirements of nearly all (97–98%) healthy individuals | ODS nutrient recommendations |
| AI (Adequate Intake) | Intake at this level is assumed to ensure nutritional adequacy | ODS nutrient recommendations |
| EAR (Estimated Average Requirement) | Average daily intake estimated to meet the requirements of 50% of healthy individuals | ODS nutrient recommendations |
| UL (Tolerable Upper Intake Level) | Maximum daily intake unlikely to cause adverse health effects | ODS nutrient recommendations |
| How a UL is derived | The NOAEL (or, if none, the LOAEL) is divided by a single uncertainty factor that covers all relevant uncertainties, such as extrapolating from animals to people or from a LOAEL | IOM 1998 |
| Nutrient | Adult UL per day | Applies to | Source |
|---|---|---|---|
| Vitamin A (preformed) | 3,000 mcg | Ages 19 and older, including pregnancy and lactation; applies to retinol and its esters from animal foods and supplements, not beta-carotene | ODS vitamin A |
| Vitamin C | 2,000 mg | Ages 19 and older | ODS vitamin C |
| Vitamin D | 100 mcg (4,000 IU) | Ages 19 and older | ODS vitamin D |
| Vitamin E | 1,000 mg | Supplemental vitamin E, adults | ODS vitamin E |
| Vitamin B6 | 100 mg | Adults, food and supplements; the Food and Nutrition Board halved the dose used in the studies it relied on | ODS vitamin B6 |
| Folate | 1,000 mcg | Synthetic forms (folic acid, 5-methyl-THF) from supplements and fortified foods; not for people treated under medical supervision | ODS folate |
| Calcium | 2,500 mg; 2,000 mg | Ages 19–50; ages 51 and older | ODS calcium |
| Zinc | 40 mg | Adults; based on the adverse effect of zinc on copper status | ODS zinc |
ULs as stated in the NIH ODS health professional fact sheets cited in each row. Most botanicals have no UL; their safety data are in the ingredient's own entry in this hub.
What “standardized” means
A standardized extract is adjusted to a stated content of named compounds so that batches match. EU guidance for herbal medicines distinguishes compounds known to carry the activity from markers used only for analysis. In the US the word has no legal definition, and NIH notes that the compounds responsible for most botanicals' effects are not known.
A useful label names the compound and its amount per serving. “Standardized” alone says neither.
| Term | Meaning | Source |
|---|---|---|
| Marker | Chemically defined constituent or group of constituents of a herbal substance, used for analysis | EMA markers paper |
| Active marker | Constituent generally accepted to contribute to the therapeutic activity | EMA markers paper |
| Analytical marker | Constituent that serves solely for analytical purposes | EMA markers paper |
| Standardized extract (EU medicines) | Adjusted to a given content of constituents with known therapeutic activity, within a tolerance, by adding excipients or blending batches | EMA quality guideline |
| Quantified extract (EU medicines) | Adjusted to a defined range of active markers, exclusively by blending batches | EMA quality guideline |
| Other extract (EU medicines) | Neither constituents with known therapeutic activity nor active markers are known | EMA quality guideline |
| “Standardized” on a US supplement | No legal or regulatory definition in the United States and not required by law; it does not necessarily indicate high quality. The constituents responsible for the effects of most botanicals are not known | ODS botanical background |
Third-party quality marks
USP and NSF verify, by testing and audits, that a product contains what its label says and is free of specified contaminants. They do not test whether it works. NIH says such seals “do not guarantee that a product is safe or effective.”
| Mark | What it verifies, as the program states it | Source |
|---|---|---|
| USP Verified Mark | Contains the ingredients listed on the label in the declared potency and amounts; does not contain harmful levels of specified contaminants; will break down and release into the body within a specified time; made under FDA current good manufacturing practices | USP Verified Mark USP Verified FAQ |
| NSF/ANSI 173 certification | Label claim review (“what's on the label is in the bottle”); no undeclared ingredients or unacceptable levels of contaminants; annual audits and periodic retesting of certified products | NSF certification NSF program basics |
| NSF Certified for Sport | Adds screening for 280 substances banned by most major athletic organizations | NSF certification |
| What no seal shows | Seals indicate a product was properly manufactured and contains the listed ingredients; “these seals do not guarantee that a product is safe or effective” | ODS botanical background |
Clean, natural, organic, non-GMO
Of these terms, only the organic tiers and bioengineered disclosure are defined in US regulation. “Natural” rests on an FDA policy that does not address health benefits, and “clean label” and “non-GMO” appear nowhere in Title 21. None of them describes efficacy. More detail: clean label.
| Term | What it means | Defined by | Source |
|---|---|---|---|
| “Clean label” | No section of Title 21 of the Code of Federal Regulations contains the phrase | Defined by the seller | eCFR search “clean label” |
| “Natural” | FDA has not defined it by rule. Its policy: nothing artificial or synthetic, including color additives, added that would not normally be expected in the food. The policy does not address production methods or health benefits | “Natural” does not mean safe (NIH ODS; FDA) | FDA “natural” ODS botanical background FDA 101 |
| “100 percent organic,” “organic” | 100%, or at least 95%, organically produced ingredients by weight or fluid volume, excluding water and salt; may carry the USDA organic seal; excluded methods (genetic engineering) prohibited | 7 CFR 205.301(a), (b), (f)(1); 205.311(a) | 7 CFR 205 subpart D USDA organic labeling |
| “Made with organic …” | At least 70% organically produced ingredients; no USDA seal | 7 CFR 205.301(c) | 7 CFR 205 subpart D USDA organic labeling |
| Bioengineered disclosure | Required by USDA for foods that contain detectable genetic material modified through certain lab techniques | National Bioengineered Food Disclosure Standard | USDA BE disclosure |
| “Non-GMO,” Non-GMO Project Verified | The phrase “non-GMO” appears in no section of Title 21 CFR; the Butterfly mark is issued by the Non-GMO Project, a 501(c)(3) nonprofit | Private verification | eCFR search “non-GMO” Non-GMO Project |
Red flags
A supplement may describe effects on the body's structure or function; it may not claim to treat disease. The warning signs below come from FDA's consumer guidance and from a review of FDA's tainted-supplement warnings, in which three product categories accounted for 98.2% of products with hidden drug ingredients.
| Warning sign | Why, in the source's words | Source |
|---|---|---|
| Claims to treat, cure, prevent or diagnose a disease | “A product intended to treat, prevent, cure, or alleviate the symptoms of a disease is a drug.” Pictures, vignettes or symbols can imply a disease claim | FDA 101 21 CFR 101.93 |
| “FDA approved” on a supplement | FDA has no authority to approve supplements for safety and effectiveness before marketing; an NDI acknowledgment is not an independent FDA finding of safety | FDA 101 FDA NDIN guidance 2024 |
| One product does it all | Products claiming to cure many diseases: “These miracle cures don't exist” | FDA 6 tip-offs |
| Personal testimonials | “Easy to make up and are not a substitute for scientific evidence” | FDA 6 tip-offs |
| Quick fixes | “Few diseases or conditions can be treated quickly” | FDA 6 tip-offs |
| “All natural” cure | “These terms don't necessarily equate to safety”; FDA found hundreds of weight-loss products sold as supplements that contained the withdrawn drug sibutramine | FDA 6 tip-offs |
| “Miracle cure,” conspiracy theories | A real cure for a serious disease would be widely reported; “the cure our government or Big Pharma doesn't want you to know about” is a stated warning sign | FDA 6 tip-offs |
| Sexual enhancement, weight loss, muscle building | 776 supplements named in FDA warnings (2007–2016) contained unapproved drug ingredients: 353 sexual enhancement (sildenafil in 166), 317 weight loss (sibutramine in 269), 92 muscle building (steroids or steroid-like ingredients in 82); 157 (20.2%) contained more than one | Tucker 2018 |
Where to check
These are government sources; none sells supplements. The entries in this hub draw on the same sources and grade the human evidence for each topic.
| Source | What it offers | Source |
|---|---|---|
| NIH Office of Dietary Supplements | Fact sheets for consumers and health professionals; the professional sheets give amounts, upper limits and an “Interactions with Medications” section | ODS zinc ODS nutrient recommendations |
| NCCIH (NIH) | Pages on individual herbs with safety and interaction notes, and a research digest on herb–drug interactions | NCCIH herb–drug digest |
| MedlinePlus (National Library of Medicine) | Herbs and Supplements A–Z index linking to NCCIH and ODS information; notes that content from the Therapeutic Research Center's Natural Medicines Comprehensive Database has been unavailable since July 29, 2025 | MedlinePlus |
| LiverTox (NIH) | Entries on drugs and supplements that have caused liver injury, with case reports and references (for example, turmeric) | LiverTox |
| FDA | Consumer information, warnings and the Safety Reporting Portal for problems | FDA 101 FDA reporting page |
Evidence grades in this hub
Each topic on an entry page is graded from what the cited source says about human evidence. When a source says the evidence is insufficient, the grade is C or D, not B.
- A
- Consistent results from several randomized controlled trials or a systematic review or meta-analysis of them, in the population described.
- B
- Some randomized trials with positive results, but small, short, few, or inconsistent.
- C
- Limited human evidence (single small trials, observational studies, or mixed results).
- D
- Laboratory or animal evidence only; not shown to work in people.
- X
- Well-designed human trials found no meaningful effect.
Where EUTECNIQ would work
EUTECNIQ would test botanical ingredients for identity, named constituents and contaminants under 21 CFR Part 111, and would state a standardized extract's marker and amount on every specification. It has no laboratory, products or data yet.
Related pages: Supplements A–Z · Documented interactions · Risk assessment · Clean label · Why supplements cannot claim to treat disease
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.